Clinical Trial Record

Return to Clinical Trials

Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection


2004-06


2017-09


2017-09


731

Study Overview

Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection

The purpose of the study is to collect pancreatic tissue, blood and urine from adults to study pancreatic abnormalities.

The aim of the study is to standardize, collect and share pancreatic cancer related information, to be used for research purposes only by researchers from different participating institutions/centers.

  • Pancreatic Cancer
    • F040514008
    • 2P50CA101955 (U.S. NIH Grant/Contract)

    Study Record Dates

    These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

    Study Registration Dates Results Reporting Dates Study Record Updates

    2007-12-24  

    N/A  

    2017-10-04  

    2007-12-24  

    N/A  

    2017-10-05  

    2008-01-02  

    N/A  

    2017-10  

    Study Plan

    This section provides details of the study plan, including how the study is designed and what the study is measuring.

    Design Details

    Primary Purpose:
    N/A


    Allocation:
    N/A


    Interventional Model:
    N/A


    Masking:
    N/A


    Arms and Interventions

    Participant Group/ArmIntervention/Treatment
    Primary Outcome MeasuresMeasure DescriptionTime Frame
    To diagnose Pancreatic Cancer5 years
    Secondary Outcome MeasuresMeasure DescriptionTime Frame
    Preventing patient form being misdiagnosed5 years

    Contacts and Locations

    This section provides the contact details for those conducting the study, and information on where this study is being conducted.

    Participation Criteria

    Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

    Ages Eligible for Study:
    ALL

    Sexes Eligible for Study:
    19 Years

    Accepts Healthy Volunteers:

      Inclusion Criteria:

    • Person over 19 years of age, patient with a tissue-proven diagnosis of pancreatic cancer at the University of Alabama at Birmingham (UAB) University Hospital during the period, and cognitive ability to provide informed consent

    • Exclusion Criteria:

    • Person not 19 or older and have not had a tissue-proven diagnosis of pancreatic cancer.

    Collaborators and Investigators

    This is where you will find people and organizations involved with this study.

    • National Cancer Institute (NCI)

    • PRINCIPAL_INVESTIGATOR: Charles M Wilcox, MD, University of Alabama at Birmingham

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available